This inventor holds 1 USPTO granted patent and 7 published patent applications. Top assignee: Myrexis, Inc.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: J Adam Willardsen: Innovator in Therapeutic Compounds
Introduction
J Adam Willardsen is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of therapeutic compounds, particularly in the development of agents that target abnormal cell growth. His work is crucial in advancing medical treatments for various clinical conditions.
Latest Patents
Willardsen holds a patent for "Compounds and therapeutical use thereof." This patent discloses 4-arylamino-quinazolines and their analogs, which are effective as activators of caspases and inducers of apoptosis. The compounds from this invention are useful in treating a variety of clinical conditions characterized by uncontrolled growth and spread of abnormal cells. He has 1 patent to his name.
Career Highlights
Willardsen is associated with Myrexis, Inc., where he continues to work on innovative solutions in the pharmaceutical field. His research focuses on developing compounds that can effectively combat diseases related to abnormal cell proliferation.
Collaborations
Some of his notable coworkers include Mark B Anderson and Warren S Weiner, who contribute to the collaborative efforts in research and development at Myrexis, Inc.
Conclusion
J Adam Willardsen's work in therapeutic compounds exemplifies the impact of innovation in medicine. His contributions are paving the way for new treatments that address critical health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile